Anixa Additional Paid In Capital from 2010 to 2024

ANIX Stock  USD 3.48  0.06  1.75%   
Anixa Biosciences Additional Paid In Capital yearly trend continues to be fairly stable with very little volatility. Additional Paid In Capital is likely to outpace its year average in 2024. Additional Paid In Capital is the excess amount paid by investors over the par value of a company's shares, representing the additional capital contributed by shareholders. View All Fundamentals
 
Additional Paid In Capital  
First Reported
2011-10-31
Previous Quarter
171 M
Current Value
175.4 M
Quarterly Volatility
64.4 M
 
Yuan Drop
 
Covid
Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 217 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Additional Paid In Capital Growth Pattern

Below is the plot of the Additional Paid In Capital of Anixa Biosciences over the last few years. Additional Paid In Capital (or APIC) is an accounting term found on Anixa Biosciences Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x Anixa Biosciences Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of Anixa Biosciences shares and does not have any impact on the value of APIC. It is the excess amount paid by investors over the par value of a company's shares, representing the additional capital contributed by shareholders. Anixa Biosciences' Additional Paid In Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.
Additional Paid In Capital10 Years Trend
Slightly volatile
   Additional Paid In Capital   
       Timeline  

Anixa Additional Paid In Capital Regression Statistics

Arithmetic Mean97,735,910
Geometric Mean0.00
Coefficient Of Variation97.41
Mean Deviation91,220,182
Median175,415,931
Standard Deviation95,206,419
Sample Variance9064.3T
Range211.8M
R-Value0.89
Mean Square Error1973.5T
R-Squared0.80
Slope19,015,400
Total Sum of Squares126899.7T

Anixa Additional Paid In Capital History

2024211.8 M
2023201.7 M
2017175.4 M

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Additional Paid In Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Additional Paid In Capital201.7 M211.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.